Chlorhexidine Mouthrinses and Plaque Control
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01138943|
Recruitment Status : Completed
First Posted : June 8, 2010
Last Update Posted : May 16, 2011
|Condition or disease||Intervention/treatment||Phase|
|Dental Plaque||Drug: Synthodont Drug: Soludent||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||30 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Investigator)|
|Official Title:||Chlorhexidine Alcohol Base Mouthrinse Versus Chlorhexidine Formaldehyde Base Mouthrinse Efficacy on Plaque Control: Double Blind, Randomized Clinical Trials|
|Study Start Date :||February 2007|
|Actual Primary Completion Date :||March 2007|
|Actual Study Completion Date :||April 2007|
|Active Comparator: Chlorhexidine alcohol-base mouthrinse||
15 ml, tree times/day for 07 days
Arm: Chlorhexidine alcohol-base mouthrinse
|Experimental: non alcohol chlorhexidine mouthrinse||
15ml of 01% Chlorhexidine non alcohol-based, 3 times a day for 7 days
Arm: Experimental: non alcohol chlorhexidine mouthrinse
- Plaque Index (PI)at Day 1 and Day 7. [ Time Frame: one week ]
The clinical trial lasted 7 days (from Day 0 to Day 7). During this period all participants abstained from all mechanical oral hygiene procedures.
On Day 0, subjects were randomly distributed in three groups: two test groups and one negative control group, and were instructed to rinse twice daily with the allocated mouthrinse during the experimental period.
The clinical measurement: Plaque Index (PI) was recorded on Day 1 and Day 7.
- Side effects [ Time Frame: at day 7 ]On Day 7, all subjects were examined for the presence or absence of tooth staining, and were questioned about taste disturbances and mucosal sensitivities.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01138943
|Faculté de Médecine Dentaire|
|Rabat, Morocco, 10 000|
|Study Chair:||Oumkeltoum Ennibi, Professor||Faculté de Médecine Dentaire|